371 related articles for article (PubMed ID: 27751767)
1. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K; Koga M; Seki T; Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE; Naruse M; Sakaguchi T; Morita S; Kosaka T; Oya M; Ogishima T; Yasuda M; Suematsu M; Kabe Y; Omura M; Nishikawa T; Mukai K
Mol Cell Endocrinol; 2017 Feb; 441():124-133. PubMed ID: 27751767
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
[TBL] [Abstract][Full Text] [Related]
3. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
4. Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation.
Nishimoto K; Seki T; Hayashi Y; Mikami S; Al-Eyd G; Nakagawa K; Morita S; Kosaka T; Oya M; Mitani F; Suematsu M; Kabe Y; Mukai K
Int J Endocrinol; 2016; 2016():7834356. PubMed ID: 27721827
[No Abstract] [Full Text] [Related]
5. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N; Umakoshi H; Seki T; Gomez-Sanchez CE; Mukai K; Suematsu M; Umezawa Y; Oya M; Kosaka T; Seki M; Suzuki Y; Horiuchi Y; Ogawa Y; Nishimoto K
J Clin Endocrinol Metab; 2022 Aug; 107(9):2439-2448. PubMed ID: 35796577
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection.
Zhang Z; Sugiura Y; Mune T; Nishiyama M; Terada Y; Mukai K; Nishimoto K
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):105-112. PubMed ID: 30608249
[TBL] [Abstract][Full Text] [Related]
7. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
[TBL] [Abstract][Full Text] [Related]
8. Pathology and gene mutations of aldosterone-producing lesions.
Nishimoto K; Ogishima T; Sugiura Y; Suematsu M; Mukai K
Endocr J; 2023 Dec; 70(12):1113-1122. PubMed ID: 37766569
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.
Nishimoto K; Tomlins SA; Kuick R; Cani AK; Giordano TJ; Hovelson DH; Liu CJ; Sanjanwala AR; Edwards MA; Gomez-Sanchez CE; Nanba K; Rainey WE
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4591-9. PubMed ID: 26240369
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical zonation in humans under normal and pathological conditions.
Nishimoto K; Nakagawa K; Li D; Kosaka T; Oya M; Mikami S; Shibata H; Itoh H; Mitani F; Yamazaki T; Ogishima T; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2010 May; 95(5):2296-305. PubMed ID: 20200334
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
[TBL] [Abstract][Full Text] [Related]
13. Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity.
Hayashi T; Zhang Z; Al-Eyd G; Sasaki A; Yasuda M; Oyama M; Gomez-Sanchez CE; Asakura H; Seki T; Mukai K; Nishimoto K
J Steroid Biochem Mol Biol; 2019 Jul; 191():105361. PubMed ID: 30974191
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
15. Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.
Nakamura Y; Maekawa T; Felizola SJ; Satoh F; Qi X; Velarde-Miranda C; Plonczynski MW; Ise K; Kikuchi K; Rainey WE; Gomez-Sanchez EP; Gomez-Sanchez CE; Sasano H
Mol Cell Endocrinol; 2014 Jul; 392(1-2):73-9. PubMed ID: 24837548
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Gomez-Sanchez CE; Gomez-Sanchez EP; Nishimoto K
Horm Metab Res; 2020 Jun; 52(6):421-426. PubMed ID: 32289837
[TBL] [Abstract][Full Text] [Related]
17. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
[TBL] [Abstract][Full Text] [Related]
18. Disordered CYP11B2 Expression in Primary Aldosteronism.
Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
[TBL] [Abstract][Full Text] [Related]
19. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism.
Sun N; Meyer LS; Feuchtinger A; Kunzke T; Knösel T; Reincke M; Walch A; Williams TA
Hypertension; 2020 Mar; 75(3):634-644. PubMed ID: 31957522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
